Using PENG block for pain relief in elderly hip fracture patients
Effect of Pericapsular Nerve Group (PENG) Block for Perioperative Analgesia in Geriatric Patients With Hip Fractures
This study is testing if a special nerve block can help older patients with hip fractures feel less pain after surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 16 (estimated) |
| Ages | 60 Years to 100 Years |
| Sex | All |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT05941221 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the pericapsular nerve group (PENG) block for providing analgesia in elderly patients undergoing surgery for hip fractures. Patients aged 60 and older, classified as ASA II or III, will receive spinal anesthesia followed by the PENG block using ultrasound guidance to enhance pain management and potentially reduce postoperative complications. The study aims to gather data on the analgesic effects and safety of this technique in the geriatric population.
Who should consider this trial
Good fit: Ideal candidates for this study are elderly patients aged 60 years or older with hip fractures classified as ASA II or III.
Not a fit: Patients younger than 60 years, those with ASA classification IV, or those who refuse the peripheral nerve block may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and recovery outcomes for elderly patients with hip fractures.
How similar studies have performed: Other studies have shown promising results with similar regional anesthesia techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients must age 60 years or more . * patients must belong to american society of anesthesiologists (ASA) classification class II or III Exclusion Criteria: * age \< 60 years * ASA IIII * refusal of peripheral nerve block * infection at the site of injection * coagulopathy INR \> 1.8 * platelets count \< 50,000 * known allergy to used medications.
Where this trial is running
Cairo
- Ain Shams University Hospital — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: Lydia E Zakhary, MD
- Email: lydia_zakhary@med.asu.edu.eg
- Phone: 00201222555128
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.